Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference55 articles.
1. European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis. EMA/CHMP/771815/2011, Rev. 2. March 2015. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500185161.pdf. Accessed 3 Feb 2020.
2. Claflin SB, Broadley S, Taylor BV. The effect of disease modifying therapies on disability progression in multiple sclerosis: a systematic overview of meta-analyses. Front Neurol. 2019;9:1–25.
3. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105–24.
4. Higgins J, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. (updated March 2011) Cochrane. www.training.cochrane.org/handbook. Accessed 7 Aug 2014.
5. Laws A, Kendall R, Hawkins N. A comparison of national guidelines for network meta-analysis. Value Health. 2014;17(5):642–54.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献